All Roads Lead to Rome Triggering Dendritic Cell Migration by Höpken, Uta E. & Lipp, Martin
Immunity
244
Figure 1. Role of the IL-1 Inflammasome in
the Activation of Caspase-1 and Release of
Active IL-1
Human monocytes stimulated with endotoxin
accumulate inactive IL-1 precursors in the
cytosol. Inactive pro-caspase-1 is constitu-
tively present in these cells. The IL-1 inflam-
masome, composed of a scaffold of interacting
proteins, activates pro-caspase-1. The cas-
pase-recruitment domain (CARD) on the pro-
caspase-1 interacts with CARD of an adaptor
protein called ASC. The pyrin (PYD) domain
of ASC binds to the PYD domain of NALP-3.
NALP-3 is comprised of the NACHT domain,
in which each of the mutations of Muckle-
Wells syndrome are found; the NALP-associ-
ated domain (NAD); and ends with leucine-
rich repeats (LRR). The CARD of caspase-1
also interacts with CARD of a protein called
Cardinal, which binds to NACHT in NALP-3
with its N-terminal domain (FIIND). The oligo-
merization of these proteins results in activa-
tion of caspase-1, which then associates with
the IL-1 precursor at the inner leaflet of the
cell’s membrane. There cleavage takes place
and active IL-1 is secreted from the cell. It is likely that more than one mechanism is involved in the secretion event. In monocytes from
subjects with Muckle-Wells syndrome bearing the mutation in NACHT (R260W), greater amounts of active IL-1 are found in the extracellular
compartment compared to cells without the mutation. High levels of secreted active IL-1 likely leads to local and systemic inflammation
associated with the mutation since the IL-1 receptor antagonist reverses the syndrome within days.
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that CD38 links innate and adaptive immunity by trig-All Roads Lead to Rome:
gering chemokine-mediated dendritic cell chemotaxis.Triggering Dendritic Cell Migration
Primary humoral responses are initiated by the ligation
of the B cell receptor (BCR) by antigen and concomitant
T cell help, which provides distinct signals for B cell
activation and differentiation. Previous work has sug-Migration of dendritic cells to secondary lymphatic
organs is a key event in acquired immunity. The role gested that the cell surface antigen CD38 acts as a
coreceptor for the BCR as well as the TCR/CD3 complexof the multifunctional ectoenzyme CD38 in humoral
immune responses has now been revisited, suggesting and modulates both B cell and T cell activation and
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Figure 1. The ADP-Ribosyl Cyclase CD38 as well as Inflammatory Lipid Mediators Trigger Chemokine Responsiveness in Dendritic Cells
Immature dendritic cells (iDCs) respond to inflammatory chemokines, i.e., CCL2, CCL3, and CCL5, through their respective chemokine receptors
CCR1, CCR2, and CCR5, which enables them to migrate to inflamed tissues. The migratory capacity of iDCs toward inflammatory chemokines
is induced upon processing of the extracellular nicotinamide-adenine-dinucleotide (NAD) by the ectoenzyme CD38 producing adenosine
diphosphate ribose (ADPR) and cyclic ADP-ribose (cADPR). Lipid mediators such as prostaglandins (PGE2) and sphingolipids (S1P) also
promote chemokine responsiveness of iDCs. Triggering of mature dendritic cells (mDCs) with the CD38-derived cADPR and NADPR or cysteinyl
leukotrienes (LTC4) renders them competent to migrate toward the homeostatic chemokines CCL19 and CCL21, which bind to their respective
chemokine receptor CCR7 expressed on mDCs. Signaling pathways utilized by CD38, lipid mediators, and chemokines are dependent on the
potent calcium (Ca2)-mobilizing activities of the second messengers cADPR, ADPR, and/or inositol triphosphate (IP3).
proliferation during such antibody responses (Lund et T cell-dependent antigens (Cockayne et al., 1998),
which, at the time, was considered an intrinsic defectal., 1998; Cesano et al., 1998). The study by Santiago
Partida-Sa´nchez and colleagues (Partida-Sa´nchez et al., of the B cell compartment. The results presented here
include a reexamination of the humoral immune re-2004) in this issue of Immunity identifies an unexpected
mechanism by which CD38 regulates T cell-dependent sponses in CD38/ mice and provide an interesting,
novel explanation for the phenotype. As expected, thehumoral immunity. Surprisingly, CD38 expression on
B cells is not required for regulating T cell-dependent authors observed reduced primary and secondary TNP-
specific IgM and IgG responses in CD38/ mice. Theantibody responses as initially believed. Instead, the
authors prove that the presence of CD38 on DCs is the antibody response was restored after reconstitution
with wild-type bone marrow (BM), indicating that CD38critical factor, as evidenced by the failure of CD38/
DCs to mobilize Ca2 in response to chemokine receptor expression on BM-derived cells is essential for T cell-
dependent humoral immune responses. Unexpectedly,activation, which results in defective chemotactic re-
sponses. the reconstitution of B cell-deficient (MT mice) mice
with a mixture of MT BM and CD38/ BM, where allCD38, a type II transmembrane glycoprotein, is widely
expressed by hematopoietic and nonhematopoietic B cells are CD38 deficient, showed similar antigen-
specific antibody responses as the control group, whichcells. Its extracellular domain acts as a multifunctional
ectoenzyme that hydrolyzes its substrate NAD to nico- received a mixture of MT BM and wild-type BM. Thus,
contrary to earlier predictions, CD38 expression on B cellstinamide and adenosine diphosphate ribose (ADPR). In
addition, CD38 functions as an ADP-ribosyl cyclase and is not essential for T-dependent humoral immune re-
sponses.produces cyclic ADPR-ribose (cADPR). Based on the
potent inositol triphosphate (IP3)-independent calcium Consequently, the authors considered the possibility
that CD38 might control the effector functions of other(Ca2)-mobilizing activities of cADPR and ADPR, CD38
has been postulated to regulate intracellular Ca2 re- antigen-presenting cells. In CD38/ mice, impaired re-
cruitment of DC precursors to inflamed skin and alteredlease and extracellular Ca2 influx in leukocytes and
nonhematopoietic cells via these second messengers migration of DCs from the skin to draining lymph nodes
correlated with reduced accumulation of lymphocytes(Figure 1; Lund et al., 1998).
In a previous study, mice deficient for CD38 displayed and DCs in lymphoid tissue.
The encounter between lymphocytes and profes-a marked alteration in humoral immune responses to
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sional antigen-presenting cells, i.e., DCs, in the specific ing molecular mechanisms promoting CCR7-dependent
microenvironments of secondary lymphoid organs is a chemotaxis through lipid mediators and their G protein-
prerequisite for the development of an acquired immune coupled receptors (GPCRs) remain to be discovered.
response and is highly dependent on the chemokine Partida-Sa´nchez and colleagues leave us with an intri-
system (Sallusto and Lanzavecchia, 1999). Partida- guing concept according to which CD38 forms a molec-
Sa´nchez et al. relate the observed humoral defects to ular link between tissue damage and potentiated che-
altered chemokine/chemokine receptor interactions as mokine responsiveness by raising the intracellular Ca2
evidenced by the failure of immature CD38/ DCs to levels after processing extracellular NAD.
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common chemotactic control mechanism for all chemo- Partida-Sa´nchez, S., Cockayne, D.A., Monard, S., Jacobson, E.L.,
kines? This seems unlikely since Partida-Sa´nchez and Oppenheimer, N., Garvy, B., Kusser, K., Goodrich, S., Howard, M.,
colleagues describe chemokines (CXCL8 [IL-8] and Harmsen, A., et al. (2001). Nat. Med. 7, 1209–1216.
CXCL1/2 [MIP-2/]) that induce Ca2 mobilization Partida-Sa´nchez, S., Goodrich, S., Kusser, K., Oppenheimer, N.,
Randall, T.D., and Lund, F.E. (2004). Regulation of dendritic celland chemotaxis of neutrophils independent of CD38
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171, 5–10.Partida-Sa´nchez et al. did not observe a reduced migra-
tory capacity for CD38-deficient T lymphocytes, and
their numbers and localization in lymphoid organs ap-
peared to be normal. The question remains why DCs
regulate chemokine receptor signaling in a CD38-depen-
dent manner, whereas T lymphocytes are seemingly in-
dependent of the ectoenzyme.
A possible explanation is that the regulatory function
of CD38 enzyme activity appears to be restricted to DC
precursors and mature DCs at sites of inflammation,
where enhanced release of the CD38 substrate NAD by
necrotic cells has been observed (Okamoto et al., 1998).
Apparently, CD38 and cADPR trigger DC trafficking
via a novel pathway differing from the signaling cas-
cades induced by other inflammatory mediators such as
sphingolipids, leukotrienes, and prostaglandins. These
lipid families have been recognized only recently as cru-
cial factors in regulating chemotaxis of immature or ma-
ture DCs (Figure 1). Interestingly, DCs triggered by cys-
teinyl leukotriene C4 (LTC4) or prostaglandin E2 (PGE2)
significantly increased their migratory capacity in re-
sponse to CCR7 ligands (Yopp et al., 2003), which is a
necessary step for their efficient mobilization into lym-
phatic vessels and homing to lymph nodes. The underly-
